NCT00108537

Non-Nicotine Agents for Smoking Cessation

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: —
• Sponsor: US Department of Veterans Affairs · Federal
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

The primary objective of this study is to determine which is the better approach to smoking cessation in veterans: bupropion combined with transdermal nicotine or high dose nicotine replacement therapy (NRT) using transdermal nicotine combined with nicotine inhaler.

Detailed description

This study is a two-arm open-label, randomized controlled trial of bupropion combined with transdermal nicotine versus high dose NRT (transdermal nicotine and nicotine inhaler) with all subjects receiving a behavioral counseling program for smoking cessation.

Conditions

• Tobacco Use Disorder

Interventions

Type	Name	Description
DRUG	bupropion and transdermal patch
DRUG	transdermal patch and nicotine inhaler

Timeline

• Start date: 2003-10-01
• Completion: 2005-09-01
• First posted: 2005-04-18
• Last updated: 2008-04-04

Locations

1 site across 1 country: United States